SAN DIEGO, Oct. 10, 2018 /PRNewswire/ -- Shareholder
rights law firm Johnson Fistel, LLP has launched an investigation
into whether the board members of Imperva, Inc. ("Imperva")
(NASDAQ: IMPV) breached their fiduciary duties in connection with
the proposed sale of the Company to Thoma
Bravo, LLC ("Thoma
Bravo).
On October 10, 2018, Imperva
announced that it had signed a definitive merger agreement with
Thoma Bravo. Under the terms of the
transaction, Imperva shareholders will receive $55.75 a share per share in cash for each share
of Imperva held.
The investigation concerns whether the Imperva board failed to
satisfy its duties to the Company shareholders, including whether
the board adequately pursued alternatives to the acquisition and
whether the board obtained the best price possible for Imperva
shares of common stock. Nationally recognized Johnson Fistel is investigating whether the
proposed deal represents adequate consideration, especially given
one Wall Street analyst has a $65.00
price target on the stock.
If you are a shareholder of Imperva and believe the
proposed buyout price is too low or you're interested in learning
more about the investigation or your legal rights and remedies,
please contact lead analyst Jim
Baker (jimb@johnsonfistel.com) at 619-814-4471. If emailing,
please include a phone number.
Additionally, you can [Click here to join this
action]. There is no cost or obligation to
you.
About Johnson Fistel,
LLP:
Johnson Fistel, LLP is a nationally
recognized shareholder rights law firm with offices in California, New
York and Georgia. The firm
represents individual and institutional investors in shareholder
derivative and securities class action lawsuits. For more
information about the firm and its attorneys, please visit
http://www.johnsonfistel.com. Attorney advertising. Past results do
not guarantee future outcomes.
Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
jimb@johnsonfistel.com
[Click here to join this action]
View original
content:http://www.prnewswire.com/news-releases/imperva-impvalert-johnson-fistel-investigates-proposed-sale-of-imperva-inc-is-55-75-a-fair-price-300728749.html
SOURCE Johnson Fistel, LLP